Tag: FDA adverse event reporting
The FDA monitors generic drug safety after approval through real-time reporting, manufacturing data, and patient feedback. Learn how adverse events are tracked, what gaps exist, and what’s changing in 2025 to improve detection of quality and effectiveness issues.
Medications
Archives
Recent-posts
Biltricide (Praziquantel) vs Alternative Anthelmintics: A Practical Comparison
Sep, 25 2025
Switching Health Plans: How to Evaluate Generic Drug Coverage and Save Money
Jun, 8 2026
Crossover Trial Design: How Bioequivalence Studies Are Structured
Dec, 15 2025
Acetaminophen vs NSAIDs in Pregnancy: Trimester Safety Guide
Jun, 15 2026
Why Lupus Support Groups Matter for Discoid and Systemic Lupus Patients
Oct, 17 2025